IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Alkermes PLC (ALKS)

CUSIP: G01767955 | Healthcare · Drug Manufacturers - Specialty & Generic | Mid Cap | 13 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile